Intestinal Research10.5217/ir.2014.12.3.2362014123236A Double-Blind, Randomized, Active Drug Comparative, Parallel-Group, Multi-Center Clinical Study to Evaluate the Safety and Efficacy of Probiotics (Bacillus licheniformis, Zhengchangsheng® capsule) in Patients with DiarrheaJun Heo, Sung Kook Kim, Kyung Sik Park, Hye Kyung Jung, Joong Goo Kwon, Byung Ik Jang
Clinical, Cosmetic and Investigational Dermatology10.2147/ccid.s231102011145Randomized, parallel-group, double-blind, controlled study to evaluate the efficacy and safety of carbohydrate-derived fulvic acid in topical treatment of eczemaJustin Gandy, Snyman, van Rensburg
Gastroenterology10.1016/s0016-5085(16)32629-420161504S775-S776Mo1786 A Multi-Center, Double-Blind, Placebo Controlled, Parallel Group, Proof of Concept Study to Evaluate the Efficacy, Safety and Tolerability of the S1P Receptor Modulator Krp203 in Subjects With Moderately Active Refractory Ulcerative ColitisHeinfried H. Radeke, J├╝rgen Stein, Wolfgang Kruis,
Nephrology Dialysis Transplantation10.1093/ndt/gfab092.0026202136Supplement_1MO148A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP, PHASE III STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LNP023 IN PRIMARY IGA NEPHROPATHY PATIENTSVlado Perkovic, Brad Rovin, Hong Zhang, Naoki Kashihara, Bart Maes, Dana Rizk, Wenyan Wang, Matthias Meier, Dmitrij Kollins, Olympia Papachristofi, Alan Charney, Jonathan Barratt,
International Journal of Colorectal Disease10.1007/s00384-019-03416-w201934111971-1978A prospective, randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of SNZ TriBac, a three-strain Bacillus probiotic blend for undiagnosed gastrointestinal discomfortRaunak Jay Soman, Malisetty Venkat Swamy,,
European Journal of Clinical Pharmacology10.1007/s00228-018-2562-x201875121-31A prospective, interventional, randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Bacillus coagulans LBSC in the treatment of acute diarrhea with abdominal discomfortChiranjit Maity, Anil Kumar Gupta,,
Diabetes10.2337/db20-945-p202069Supplement_1945-P: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Cohort Study to Evaluate the Efficacy and Safety of 12 Once-Weekly Subcutaneous Doses of PB-119 to Patients with Type 2 Diabetes Mellitus as MonotherapyMIN XU,,
Clinical Therapeutics10.1016/j.clinthera.2013.09.017201335111830-1840A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of the Extended-Release Tramadol Hydrochloride/Acetaminophen Fixed-Dose Combination Tablet for the Treatment of Chronic Low Back PainJae Hyup Lee, Chong-Suh Lee,
American Journal of Gastroenterology10.1038/ajg.2016.51120171121145-151Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Benefit of the Probiotic Bifidobacterium infantis 35624 in Non-Patients With Symptoms of Abdominal Discomfort and BloatingTamar Ringel-Kulka, Johnson McRorie, Yehuda Ringel,,,
Journal of the American Academy of Dermatology10.1016/j.jaad.2009.11.0432010623AB2Multicenter, randomized, parallel-group, double-blind, vehicle-controlled study to evaluate the efficacy and safety of PEP005 (ingenol mebutate) gel, 0.05% in patients with actinic keratoses on nonhead locations,